00:00:00Introduction
00:01:33First-Line Treatment
00:20:36Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapy
À PROPOS DE CET ÉPISODE
Anglais
États-Unis
MONTRER LES NOTES 🔗
TRANSCRIPTION 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
RECHERCHER LES ÉPISODES PASSÉS
Rechercher les épisodes précédents de Hematologic Oncology Update.
AUTRES ÉPISODES DANS CE PODCAST
Featuring perspectives from Prof John Seymour, including the following topics:
Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)
Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21)
First-line treatment with sonrotocl…
Featuring perspectives from Dr William G Wierda, including the following topics:
Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00)
Sequencing Road Map (12:39)
Key Datasets — Pirtobrutinib (21:08)
Investigator Survey (34:09)
Chimeric Antigen Receptor T-Cell T…
Featuring perspectives from Dr Matthew Matasar and Dr Sonali M Smith, including the following topics:
Introduction: Lymphoma Survivorship (0:00)
Novel Treatment Approaches for Diffuse Large B-Cell Lymphoma — Dr Matasar (6:49)
Novel Treatment Approaches for Follicular Lymphoma and Mantle Cell Lymph…
Featuring perspectives from Dr Jeremy S Abramson, Dr Joshua Brody, Dr Manali Kamdar, Dr Tycel Phillips and Dr Jason Westin, moderated by Dr Abramson, including the following topics:
Introduction (0:00)
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Ka…
Featuring perspectives from Dr Amrita Krishnan and Dr Robert Z Orlowski, including the following topics:
Introduction (00:00)
Up-Front Progression-Free Survival for Standard-Risk Disease — 2006, 2016 (1:47)
Current and Emerging Therapeutic Approaches — Dr Orlowski (10:34)
Chimeric Antigen Receptor…
Avertissement: Le podcast et les illustrations intégrés sur cette page proviennent de Dr. Neil Love, qui est la propriété de son propriétaire et n'est ni affilié ni approuvé par Listen Notes, Inc.
MODIFIER
Merci de nous avoir aidé à tenir la base de données de podcasts à jour.
